论文部分内容阅读
我科近年来临床使用普瑞博思、假密环菌甲素片及硫糖铝三联药物治疗胆汁返流性胃炎(RG)52例,疗效满意.现报告如下:1 临床资料1.1 一般资料:本组病例均经电子纤维胃镜、活组织病理检查及胃液pH值测定,病程1月～3年.随机分为治疗组和对照组.治疗组52例,男性27例,女性25例,年龄21～55岁,RG24例,术后RG28例(Ⅰ式12例,Ⅱ式16例).对照组51例,男性25例,女性26例,年龄19～57岁,RG23例,术后RG28例(Ⅰ式13例,Ⅱ式15例).
In recent years, our department in clinical use of Pregabalus, fimbrin and sucralfate triple drug treatment of bile reflux gastritis (RG) in 52 cases, the results are as follows: 1 Clinical data 1.1 General information: The patients were divided into treatment group and control group randomly by electronic fiber endoscopy, biopsy and gastric juice pH value for 1 month to 3 years.The treatment group of 52 patients, 27 males and 25 females, aged 21 ~ 55 cases, RG24 cases and RG28 cases (12 cases of type I and 16 cases of type Ⅱ), 51 cases of control group, 25 cases of males and 26 cases of females, aged from 19 to 57 years old, RG23 cases and RG28 cases Type 13 cases, type Ⅱ 15 cases).